CNBCTV18
On the financial front, Biocon recently raised ₹4,500 crore through a qualified institutional placement (QIP), its first capital raise since its initial public offering (IPO) over 20 years ago…
Read More
Biocon Biologics eyes global expansion with focus on insulin and GLP-1 therapies
On the financial front, Biocon recently raised ₹4,500 crore through a qualified institutional placement (QIP), its first capital raise since its initial public offering (IPO) over 20 years ago…